Publications 2015

Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, et al. A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial. Clin Infect Dis. 1 août 2015;61(3):375‑84. Disponible sur:

Antiretroviral Therapy Cohort Collaboration (ART-CC). Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antivir Ther. 2015;20(1):21‑8. Disponible sur:

Antiretroviral Therapy Cohort Collaboration (ART-CC), Vandenhende M-A, Ingle S, May M, Chene G, Zangerle R, et al. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS. 28 janv 2015;29(3):373‑83. Disponible sur:

Bruyand M, Le Marec F, Lavole A, Leffondre K, Spano JP, Le Moing V, et al. Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study. AIDS. 1 juin 2015;29(9):1105‑9. Disponible sur:

Cacoub P, Dabis F, Costagliola D, Almeida K, Lert F, Piroth L, et al. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int. 1 janv 2015;35(1):65‑70. Disponible sur:

Champredon D, Bellan SE, Delva W, Hunt S, Shi C-F, Smieja M, et al. The effect of sexually transmitted co-infections on HIV viral load amongst individuals on antiretroviral therapy: a systematic review and meta-analysis. BMC Infect Dis. 30 juin 2015;15(1):249. Disponible sur:

de Monteynard L-A, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard J-L, et al. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France. PLoS One. 3 mars 2015;10(3):e0118492. Disponible sur:

Delaugerre C, Ghosn J, Lacombe J-M, Pialoux G, Cuzin L, Launay O, et al. Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access. Clin Infect Dis. 1 févr 2015;60(3):463‑72. Disponible sur:

Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Melica G, et al. Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France. Clin Infect Dis. 15 oct 2015;61(8):1273‑80. Disponible sur:

Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, et al. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 15 avr 2015;60(8):1269‑77. Disponible sur:

Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 14 janv 2015;29(2):221‑9. Disponible sur:

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, et al. Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Clin Infect Dis. 15 avr 2015;60(8):1262‑8. Disponible sur:

Hleyhel M, Belot A, Bouvier A-M, Tattevin P, Pacanowski J, Genet P, et al. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. Int J cancer. 15 nov 2015;137(10):2443‑53. Disponible sur:

Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, Mussini C, et al. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? AIDS. 1 nov 2015;29(17):2323‑33. Disponible sur:

Lang S, Lacombe J-M, Mary-Krause M, Partisani M, Bidegain F, Cotte L, et al. Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort. PLoS One. 22 juill 2015;10(7):e0133358. Disponible sur:

Late presenters working group in COHERE in EuroCoord, Mocroft A, Lundgren J, Antinori A, Monforte A d’Arminio, Brännström J, et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47). Disponible sur:

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, et al. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study. lancet HIV. 1 août 2015;2(8):e335-43. Disponible sur:

Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, et al. Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults. AIDS. 14 janv 2015;29(2):193‑200. Disponible sur:

May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, et al. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration. J Acquir Immune Defic Syndr. 1 juill 2015;69(3):348‑54. Disponible sur:

Migrants Working Group on behalf of COHERE in EuroCoord. Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study. lancet HIV. 1 déc 2015;2(12):e540-9. Disponible sur:

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, et al. Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice. PLoS One. 1 déc 2015;10(12):e0144746. Disponible sur:

Pourcher G, Costagliola D, Martinez V. Obesity in HIV-infected patients in France: prevalence and surgical treatment options. J Visc Surg. 1 févr 2015;152(1):33‑7. Disponible sur:

Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T, et al. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey. HIV Med. 1 avr 2015;16(4):230‑9. Disponible sur:

Vandenhende M-A, Roussillon C, Henard S, Morlat P, Oksenhendler E, Aumaitre H, et al. Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000. PLoS One. 17 juin 2015;10(6):e0129550. Disponible sur: